Andrew P. Combs

Person

Kenneth Square, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Aminopyrazine diol compounds as PI3K-y inhibitors
- Patent number 12,365,668
- Issue date Jul 22, 2025
- Incyte Corporation
- Stacey Shepard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6...
- Patent number 12,227,502
- Issue date Feb 18, 2025
- Incyte Corporation
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclylamines as PI3K inhibitors
- Patent number 12,201,636
- Issue date Jan 21, 2025
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
- Patent number 12,173,006
- Issue date Dec 24, 2024
- Incyte Corporation
- Brent Douty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ r...
- Patent number 12,152,033
- Issue date Nov 26, 2024
- Incyte Corporation
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 12,129,262
- Issue date Oct 29, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors
- Patent number 12,030,885
- Issue date Jul 9, 2024
- Incyte Corporation
- Andrew W. Buesking
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic derivatives as PI3K inhibitors
- Patent number 12,006,320
- Issue date Jun 11, 2024
- Incyte Corporation
- Stacey Shepard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors
- Patent number 11,999,751
- Issue date Jun 4, 2024
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
- Patent number 11,952,367
- Issue date Apr 9, 2024
- Incyte Corporation
- Richard B. Sparks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,939,340
- Issue date Mar 26, 2024
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tertiary alcohols as PI3K-γ inhibitors
- Patent number 11,926,630
- Issue date Mar 12, 2024
- Incyte Corporation
- Brent Douty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aminopyrazine diol compounds as PI3K-γ inhibitors
- Patent number 11,926,616
- Issue date Mar 12, 2024
- Incyte Corporation
- Stacey Shepard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclylamines as PI3K inhibitors
- Patent number 11,819,505
- Issue date Nov 21, 2023
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as PI3K-γ inhibitors
- Patent number 11,773,102
- Issue date Oct 3, 2023
- Incyte Corporation
- Artem Shvartsbart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BRM targeting compounds and associated methods of use
- Patent number 11,702,423
- Issue date Jul 18, 2023
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H...
- Patent number 11,702,416
- Issue date Jul 18, 2023
- Incyte Corporation
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,685,744
- Issue date Jun 27, 2023
- Prelude Therapeutics Incorporated
- Andrew W. Buesking
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CDK inhibitors and their use as pharmaceuticals
- Patent number 11,673,893
- Issue date Jun 13, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCL-2 inhibitors and their use as pharmaceuticals
- Patent number 11,622,970
- Issue date Apr 11, 2023
- Prelude Therapeutics Incorporation
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic heterocycles as BET protein inhibitors
- Patent number 11,498,926
- Issue date Nov 15, 2022
- Incyte Corporation
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclylamines as PI3K inhibitors
- Patent number 11,433,071
- Issue date Sep 6, 2022
- Incyte Corporation
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidinones as PI3K inhibitors
- Patent number 11,401,280
- Issue date Aug 2, 2022
- Incyte Holdings Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic derivatives as PI3K inhibitors
- Patent number 11,396,502
- Issue date Jul 26, 2022
- Incyte Corporation
- Stacey Shepard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine and pyridimine compounds as PI3K-gamma inhibitors
- Patent number 11,352,340
- Issue date Jun 7, 2022
- Incyte Corporation
- Richard B. Sparks
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related...
- Patent number 11,306,079
- Issue date Apr 19, 2022
- Incyte Corporation
- Artem Shvartsbart
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tertiary alcohols as PI3K-γ inhibitors
- Patent number 11,225,486
- Issue date Jan 18, 2022
- Incyte Corporation
- Brent Douty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
- Patent number 11,207,302
- Issue date Dec 28, 2021
- Incyte Corporation
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of indoleamine 2,3-dioxygenase and methods of using the...
- Patent number 11,192,868
- Issue date Dec 7, 2021
- Incyte Corporation
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor
- Patent number 11,186,580
- Issue date Nov 30, 2021
- Incyte Corporation
- Brent Douty
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Polymorphic Compounds And Uses Thereof
- Publication number 20250197418
- Publication date Jun 19, 2025
- Prelude Therapeutics Incorporated
- Bo Shen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20250163074
- Publication date May 22, 2025
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KAT6 Targeting Compounds
- Publication number 20250161289
- Publication date May 22, 2025
- Prelude Therapeutics Incorporated
- Chun Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H...
- Publication number 20250145621
- Publication date May 8, 2025
- INCYTE CORPORATION
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS
- Publication number 20250129098
- Publication date Apr 24, 2025
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
- Publication number 20250074916
- Publication date Mar 6, 2025
- Prelude Therapeutics Incorporated
- Artem Shvartsbart
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A CDK9 INHIBITOR AND USES THEREOF
- Publication number 20250011298
- Publication date Jan 9, 2025
- Prelude Therapeutics Incorporated
- Ganfeng CAO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS
- Publication number 20240400541
- Publication date Dec 5, 2024
- INCYTE CORPORATION
- Stacey Shepard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240352029
- Publication date Oct 24, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20240336612
- Publication date Oct 10, 2024
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240246993
- Publication date Jul 25, 2024
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TERTIARY ALCOHOLS AS PI3K-y INHIBITORS
- Publication number 20240228498
- Publication date Jul 11, 2024
- INCYTE CORPORATION
- Brent Douty
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLYLAMINES AS PI3K INHIBITORS
- Publication number 20240216377
- Publication date Jul 4, 2024
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BRM Targeting Compounds and Associated Methods of Use
- Publication number 20240190886
- Publication date Jun 13, 2024
- Prelude Therapeutics Incorporated
- Corey Howard Basch
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase
- Publication number 20240173303
- Publication date May 30, 2024
- INCYTE CORPORATION
- Andrew P. Combs
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20240165244
- Publication date May 23, 2024
- Prelude Therapeutics Incorporated
- Corey Howard Basch
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240150340
- Publication date May 9, 2024
- Prelude Therapeutics Incorporated
- Xiaowei Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS
- Publication number 20240124422
- Publication date Apr 18, 2024
- Prelude Therapeutics Incorporated
- Chun Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE
- Publication number 20240018158
- Publication date Jan 18, 2024
- Prelude Therapeutics Incorporated
- Hong Lin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20240018136
- Publication date Jan 18, 2024
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H...
- Publication number 20240002381
- Publication date Jan 4, 2024
- INCYTE CORPORATION
- Andrew P. Combs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KAT6 TARGETING COMPOUNDS
- Publication number 20230416240
- Publication date Dec 28, 2023
- Prelude Therapeutics Incorporated
- Sarah Pawley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BRM Targeting Compounds And Associated Methods Of Use
- Publication number 20230365576
- Publication date Nov 16, 2023
- Prelude Therapeutics Incorporated
- John A. Rose
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMI...
- Publication number 20230357275
- Publication date Nov 9, 2023
- Prelude Therapeutics, Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230357265
- Publication date Nov 9, 2023
- Prelude Therapeutics, Incorporated
- Andrew W. Buesking
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heterocycle CDK Inhibitors And Their Use Thereof
- Publication number 20230265083
- Publication date Aug 24, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230257394
- Publication date Aug 17, 2023
- Prelude Therapeutics, Incorporated
- Jincong ZHUO
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230242543
- Publication date Aug 3, 2023
- Prelude Therapeutics Incorporated
- Liang Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK Inhibitors And Their Use As Pharmaceuticals
- Publication number 20230234964
- Publication date Jul 27, 2023
- Prelude Therapeutics Incorporated
- Jincong Zhuo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEU...
- Publication number 20230212191
- Publication date Jul 6, 2023
- PRELUDE THERAPEUTICS, INCORPORATED
- Jincong ZHUO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andrew P. Combs

Person

Patents Grantslast 30 patents

Aminopyrazine diol compounds as PI3K-y inhibitors

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c] pyridin-7(6...

Heterocyclylamines as PI3K inhibitors

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

Use of pyrazolopyrimidine derivatives for the treatment of PI3K-δ r...

CDK inhibitors and their use as pharmaceuticals

Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors

Heterocyclic derivatives as PI3K inhibitors

Bicyclic heteroarylaminoalkyl phenyl derivatives as PI3K inhibitors

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

CDK inhibitors and their use as pharmaceuticals

Tertiary alcohols as PI3K-γ inhibitors

Aminopyrazine diol compounds as PI3K-γ inhibitors

Heterocyclylamines as PI3K inhibitors

Heterocyclic compounds as PI3K-γ inhibitors

BRM targeting compounds and associated methods of use

1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H...

CDK inhibitors and their use as pharmaceuticals

CDK inhibitors and their use as pharmaceuticals

BCL-2 inhibitors and their use as pharmaceuticals

Tricyclic heterocycles as BET protein inhibitors

Heterocyclylamines as PI3K inhibitors

Pyrimidinones as PI3K inhibitors

Substituted heterocyclic derivatives as PI3K inhibitors

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related...

Tertiary alcohols as PI3K-γ inhibitors

1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase

Modulators of indoleamine 2,3-dioxygenase and methods of using the...

Crystalline forms of a phosphoinositide 3-kinase (PI3K) inhibitor

Patents Applicationslast 30 patents

Polymorphic Compounds And Uses Thereof

CDK Inhibitors And Their Use As Pharmaceuticals

KAT6 Targeting Compounds

1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H...

BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

CRYSTALLINE FORMS OF A CDK9 INHIBITOR AND USES THEREOF

AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS

CDK Inhibitors And Their Use As Pharmaceuticals

BRM Targeting Compounds And Associated Methods Of Use

CDK Inhibitors And Their Use As Pharmaceuticals

TERTIARY ALCOHOLS AS PI3K-y INHIBITORS

HETEROCYCLYLAMINES AS PI3K INHIBITORS

BRM Targeting Compounds and Associated Methods of Use

1,2,5-Oxadiazoles As Inhibitors Of Indoleamine 2,3- Dioxygenase

BRM Targeting Compounds And Associated Methods Of Use

CDK Inhibitors And Their Use As Pharmaceuticals

MUTANT PI3K-ALPHA INHIBITORS AND THEIR USE AS PHARMACEUTICALS

BRM TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

CDK Inhibitors And Their Use As Pharmaceuticals

1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H...

KAT6 TARGETING COMPOUNDS

BRM Targeting Compounds And Associated Methods Of Use

SPIRO-SULFONAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEUKEMI...

CDK Inhibitors And Their Use As Pharmaceuticals

Heterocycle CDK Inhibitors And Their Use Thereof

CDK Inhibitors And Their Use As Pharmaceuticals

CDK Inhibitors And Their Use As Pharmaceuticals

CDK Inhibitors And Their Use As Pharmaceuticals

SPIRO-SULFONIMIDAMIDE DERIVATIVES AS INHIBITORS OF MYELOID CELL LEU...